top of page
OrganOx Acquired by Terumo Corporation in ~$1.5 Billion Deal to Accelerate Global Transplant Technology
$1.5 billion acquisition strengthens global leadership in organ technology and accelerates progress toward making every organ count Oxford, England and Madison, New Jersey, October 30, 2025 - OrganOx Ltd. today announced the completion of its acquisition by Terumo Corporation, following satisfaction of all customary regulatory and closing conditions. OrganOx is now a wholly owned subsidiary of Terumo, positioning the company to unlock new opportunities to evolve its technolog
Orsco Lifesciences AG
Nov 32 min read
Terumo to acquire OrganOx in ~$1.5B deal, entering organ-transplant technology
TOKYO — Aug. 25, 2025.  Terumo (TSE: 4543) has signed a definitive agreement to acquire UK-based OrganOx, a pioneer in normothermic...
Orsco Lifesciences AG
Aug 251 min read
OrganOx Closes Second Private Placement, Raising $160M for NMP Platform Expansion
Oxford, UK & Madison, NJ — May 8, 2025.  OrganOx Ltd. has completed a second closing of its private placement, securing investments from...
Orsco Lifesciences AG
May 71 min read
Phagenesis raises $42M to accelerate U.S. rollout of dysphagia therapy
Manchester, UK — Mar 4, 2024.  Phagenesis closed a $42 million Series D  to scale U.S. commercialization of Phagenyx® , its...
Orsco Lifesciences AG
Mar 41 min read
OrganOx Raises $142M Financing Led by HealthQuest Capital
Oxford, UK & Madison, NJ — Feb 24, 2025.  OrganOx Ltd. has completed an oversubscribed $142 million equity financing  (primary and...
Orsco Lifesciences AG
Feb 242 min read
bottom of page